Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LSTR vs ZOE Pulpectomy for Primary Molars With Pulp Necrosis
NCT07475364Phase 2Not yet recruiting
- Sponsor
- The University of Faisalabad
- Start
- May 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of chloramphenicol + tetracycline + zinc oxide + eugenol in pulp necrosis, sponsored by The University of Faisalabad. Planned start May 2026; status: not yet recruiting.
02
Drugs
chloramphenicol + tetracycline + zinc oxide + eugenol
03
Conditions
pulp necrosis
Beyond the preview
Go deeper on NCT07475364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07475364.